SCHEMBL24508233

SCHEMBL24508233

CN(C)C(=O)c1cc2ccccc2cc1NN

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 3/20 0.44
MITF O75030 1/20 0.44
GAA P10253 1/20 0.44
NCOA1 Q15788 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
GFER P55789 1/20 0.42
NGLY1 Q96IV0 1/20 0.42
ABCC1 P33527 1/20 0.42
PTPN1 P18031 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 1/20 0.41
NCEH1 Q6PIU2 1/20 0.40
IDO1 P14902 1/20 0.40
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5391933 0.79 MAPT (0.66) MEN1KMT2AMAPTMITFGAA
SCHEMBL5401765 0.77 IDO1 (0.61) MEN1KMT2AMAPTMITFGAA
SCHEMBL24508227 0.73 GAA (0.46) MEN1KMT2AMAPTGAAGFER
SCHEMBL219397 0.71 ALDH1A1 (0.42) MEN1KMT2AMAPTMITFGAA
SCHEMBL8377331 0.69 ALDH1A1 (0.61) MEN1KMT2AMAPTGAAPTPN1
SCHEMBL7349368 0.69 BRD4 (0.53) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL188296 0.69 MEN1 (0.65) MEN1KMT2AMAPTGAASMN1; SMN2
SCHEMBL10745976 0.67 POLB (0.54) MEN1KMT2AMAPTGAAABCC1
SCHEMBL29023878 0.66 MAPT (0.78) MEN1KMT2AMAPTMITFGAA
SCHEMBL10407111 0.66 NR4A1 (0.59) MEN1KMT2AMAPTTDP1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185841-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND HYDRAZINE DERIVATIVE FUJIFILM CORPORATION (JP) 2022-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185841-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND HYDRAZINE DERIVATIVE VIP, HRH1, NGLY1 MEN1 682/4885KMT2A 1820/4885MAPT 4286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.